Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Mind the (biomedical funding) gap

Article Abstract:

The predicament faced by four key constituents that include venture capitalist, philanthropic organizations, academia and government in the area of venture capital funding gap is presented. Experts conclude that although venture capitalists are in a great position to assess the funding gap at any given time, they are not going to commit any unnatural acts to bridge this gap.

Author: Klausner, Arthur
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Biomedical engineering

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The importance of angels in starting a US biotech venture

Article Abstract:

Angel investors were in existence for many years, providing seed funds for ventures from the Bell Telephone Company in 1874 to the 1944 investment. Angels provide the entrepreneur with valuable know-how in starting and growing a business and provide start up capital of about $40-60 million for US biotech entrepreneurial ventures.

Author: Sohl, Jeffrey
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Joint ventures, Company joint venture

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Biotech venture capital-it's not too late to be early

Article Abstract:

Venture capital funding raised by biotech companies is approaching the heights. Venture capital's are becoming increasingly disenchanted with the risk-return profile of early-stage drug discovery projects and they have begun to form startup companies around relatively late-stage assets.

Author: Klausner, Arthur
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Venture capital

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Biotechnology industry, Biotechnology industries, Finance, Company financing
Similar abstracts:
  • Abstracts: Taking the pain out of getting paid. Midsize custom-fit. My hotel was cheaper than yours
  • Abstracts: Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity
  • Abstracts: Gene prioritization through genomic data fusion. Discovery of regulatory elements in vertebrates through comparative genomics
  • Abstracts: Does judicial efficiency lower the cost of credit? The impact of CRA agreements on community banks. Credit risk modeling with affine processes
  • Abstracts: V-22 Osprey program disputes 'out' call on icing incident. Lockheed CSAR entrant proven in Iraq, Company says
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.